BCL-2 family antagonists for cancer therapy
Guillaume Lessene, Peter E Czabotar, Peter M Colman
Nature Reviews Drug Discovery | NATURE PUBLISHING GROUP | Published : 2008
We acknowledge helpful discussions with D. Huang and many other colleagues at The Walter and Eliza Hall Institute of Medical Research including J. Adams, J. Baell, S. Cory, D. Fairlie, E. Lee and K. Watson. Work in the authors' laboratories is supported by the National Health and Medical Research Council (Australia), The Leukemia and Lymphoma Society (USA), The Cancer Council of Victoria and The Australian Cancer Research Foundation.